Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mini device implanted in liver tumors could personalize cancer treatment

NCT ID NCT07193862

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 34 times

Summary

This early-phase study tests a small implantable device placed directly into liver tumors to see how they respond to cancer drugs. Ten adults with colorectal cancer that has spread to the liver will have the device inserted a few days before planned surgery to remove the tumor. The goal is to check if the procedure is safe and if the device can measure drug effects on the surrounding tissue, which may help guide future treatment choices.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Long Island Jewish Medical Center

    RECRUITING

    New Hyde Park, New York, 11040, United States

    Contact

  • RJ Zuckerberg

    RECRUITING

    Lake Success, New York, 11042, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.